Kingsley Kyle Eugene - 17 Dec 2024 Form 4 Insider Report for Vireo Growth Inc. (VREOF)

Role
Co-Executive Chairman
Signature
/s/ Nicole A. Edmonds, Attorney-in-Fact for Kyle E. Kingsley
Issuer symbol
VREOF
Transactions as of
17 Dec 2024
Net transactions value
$0
Form type
4
Filing time
19 Dec 2024, 16:48:34 UTC
Previous filing
02 Aug 2023
Next filing
30 Dec 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VREOF Subordinate Voting Shares Award $0 +7,000,000 +107% $0.000000 13,541,100 17 Dec 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents subordinate voting shares underlying restricted stock units ("RSUs") granted to Dr. Kingsley. The RSUs are granted under the Vireo Health International Inc. 2019 Equity Incentive Plan, as amended, and become vested on the following schedule: 3,500,000 on December 17, 2025 with the balance vesting in equal installments of 875,000 on March 17, 2026, June 17, 2026, September 17, 2026, and December 17, 2026 (subject to Dr. Kingsley remaining a Service Provider on each such vesting date) or (i) the date of a change in control of the Parent Company or the Employer; or (ii) promptly following (and in no case later than 20 days) Dr. Kingsley's separation from service (as defined in 409A of the Internal Revenue Code) by the Employer (with or without Cause).

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney